| 000 | 01756 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516094706.0 | ||
| 264 | 0 | _c20121207 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1590-3729 | ||
| 024 | 7 |
_a10.1016/j.numecd.2012.04.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLepore, G | |
| 245 | 0 | 0 |
_aBolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes. _h[electronic resource] |
| 260 |
_bNutrition, metabolism, and cardiovascular diseases : NMCD _cAug 2012 |
||
| 300 |
_ae15-6 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAutomation |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aBlood Glucose Self-Monitoring _xinstrumentation |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 | _aEquipment Design |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aInfusions, Subcutaneous |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin Infusion Systems |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSoftware Design |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDodesini, A R | |
| 700 | 1 | _aNosari, I | |
| 700 | 1 | _aScaranna, C | |
| 700 | 1 | _aCorsi, A | |
| 700 | 1 | _aTrevisan, R | |
| 773 | 0 |
_tNutrition, metabolism, and cardiovascular diseases : NMCD _gvol. 22 _gno. 8 _gp. e15-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.numecd.2012.04.001 _zAvailable from publisher's website |
| 999 |
_c21842999 _d21842999 |
||